You have 9 free searches left this month | for more free features.

City

Bethesda (2)

Edmonton (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 3 (1)

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

University of Alberta (1)

Collaborator

Intervention

18f-dopa (3)

18-fdg (1)

68ga-dotatate (1)

ct scan (1)

furosemide injection (1)

mri (1)

pentetreotide (1)

Study Documents

Intervention Type

drug (3)

device (1)

Funder Type

NIH (2)

Other (1)

Study Type

Interventional (3)

18f-dopa

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Congenital Hyperinsulinism, Neuroblastoma, Parkinson Disease Trial in Edmonton (18F-DOPA, Furosemide Injection)

Recruiting

Congenital Hyperinsulinism
+5 more

18F-DOPA
Furosemide Injection

Edmonton, Alberta, Canada

WC Mackenzie Health Science Centre / University of Alberta Hospi

Apr 11, 2022

Hyperparathyroidism, Hypercalcemia, Parathyroid Tumor Trial run by the NIDDK (68Ga-Dotatate, 18F-DOPA)

Completed

Hyperparathyroidism
+4 more

68Ga-Dotatate
18F-DOPA

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

May 12, 2022

Cushing Syndrome, Endocrine Disease Trial run by the NICHD (Pentetreotide, 18F-DOPA, CT scan)

Completed

Cushing Syndrome
Endocrine Disease

Pentetreotide
+4 more

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Mar 19, 2021